Todd Pettingill | Investor Relations |
John Higgins | Chief Executive Officer |
Matt Foehr | Chief Operating Officer |
Matt Korenberg | Chief Financial Officer |
Larry Solow | CJS Securities |
Hello, and welcome to the Ligand Pharmaceuticals Q1 2019 Earnings Call. My name is Ian, and I will be your web event specialist today. [Operator Instructions] And my pleasure to turn webcast over to Todd Pettingill. Todd, the floor is yours.
Welcome to Ligand’s First Quarter of 2019 Financial Results and Business Update Conference Call.